Work

Mechanistic Evaluation and In Vivo Validation of a Novel HIPK2 Inhibitor as Anti-Fibrosis Therapy for Kidney Disease

Year: 2022

Type: conference-abstract

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20223311s1585c

Authors: Kyung Lee, Ye Feng, Yibang Chen, Richard T. Beresis, Robert Drakas, John C. He

Institution: Icahn School of Medicine at Mount Sinai

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396990443

Cites:

Cited by:

Related to: 10